These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 18494823

  • 1. CD4-negative variant of CD4+/CD56+ hematodermic neoplasm: description of three cases.
    Ascani S, Massone C, Ferrara G, Rongioletti F, Papini M, Pileri S, Cerroni L.
    J Cutan Pathol; 2008 Oct; 35(10):911-5. PubMed ID: 18494823
    [Abstract] [Full Text] [Related]

  • 2. Blastic NK-cell lymphomas (agranular CD4+CD56+ hematodermic neoplasms): a review.
    Petrella T, Bagot M, Willemze R, Beylot-Barry M, Vergier B, Delaunay M, Meijer CJ, Courville P, Joly P, Grange F, De Muret A, Machet L, Dompmartin A, Bosq J, Durlach A, Bernard P, Dalac S, Dechelotte P, D'Incan M, Wechsler J, Teitell MA.
    Am J Clin Pathol; 2005 May; 123(5):662-75. PubMed ID: 15981806
    [Abstract] [Full Text] [Related]

  • 3. TCL1 and CLA expression in agranular CD4/CD56 hematodermic neoplasms (blastic NK-cell lymphomas) and leukemia cutis.
    Petrella T, Meijer CJ, Dalac S, Willemze R, Maynadié M, Machet L, Casasnovas O, Vergier B, Teitell MA.
    Am J Clin Pathol; 2004 Aug; 122(2):307-13. PubMed ID: 15323148
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. CD4+/CD56+ hematodermic neoplasm ("blastic natural killer cell lymphoma"): neoplastic cells express the immature dendritic cell marker BDCA-2 and produce interferon.
    Pilichowska ME, Fleming MD, Pinkus JL, Pinkus GS.
    Am J Clin Pathol; 2007 Sep; 128(3):445-53. PubMed ID: 17709319
    [Abstract] [Full Text] [Related]

  • 6. Cutaneous CD4+ CD56+ hematologic malignancies.
    Magro CM, Porcu P, Schaefer J, Erter JW, Furman RR, Shitabata PK, Crowson AN.
    J Am Acad Dermatol; 2010 Aug; 63(2):292-308. PubMed ID: 20541283
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Primary cutaneous CD4+/CD56+ hematodermic neoplasm (blastic NK-cell lymphoma): a report of five cases.
    Ng AP, Lade S, Rutherford T, McCormack C, Prince HM, Westerman DA.
    Haematologica; 2006 Jan; 91(1):143-4. PubMed ID: 16434387
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. CD4+/CD56+ hematodermic tumor: the features of an evolving entity and its relationship to dendritic cells.
    Herling M, Jones D.
    Am J Clin Pathol; 2007 May; 127(5):687-700. PubMed ID: 17439829
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. CD4/CD56 hematodermic neoplasm: a report of three cases.
    Ji H, Wang L, Li D, Zhang W, Wan C, Xu C, Li G.
    Int J Dermatol; 2009 Jul; 48(7):743-8. PubMed ID: 19570082
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.